Literature DB >> 19383893

Risk of endometrial cancer in relation to medical conditions and medication use.

Joan Fortuny1, Camelia Sima, Sharon Bayuga, Homer Wilcox, Katherine Pulick, Shameka Faulkner, Ann G Zauber, Sara H Olson.   

Abstract

We studied the relation of medical conditions related to obesity and medications used for these conditions with endometrial cancer. We also investigated the association of other medical conditions and medications with risk. This U.S. population-based case-control study included 469 endometrial cancer cases and 467 controls. Information on putative risk factors for endometrial cancer was collected through personal interviews. We asked women about their medical history and medications used for six months or longer and the number of years each medication was taken. Risk was strongly associated with increasing obesity (P for trend < 0.001). Among the conditions related to obesity, and after adjustment for age, body mass index, and other risk factors and conditions, uterine fibroids were independently related to an increased cancer risk [adjusted odds ratio (OR), 1.8; 95% confidence interval (95% CI), 1.2-2.5]. Although hypertension was not significantly related to endometrial cancer after adjustment for age and body mass index, the use of thiazide diuretics was independently associated with increased risk (OR, 1.8; 95% CI, 1.1-3.0). Anemia was associated with decreased risk (OR, 0.6; 95% CI, 0.5-0.9). Use of nonsteroidal anti-inflammatory drugs was related to a decreased risk (OR, 0.7; 95% CI, 0.5-0.97). To our knowledge, the observation about thiazide diuretics is novel and requires confirmation in other studies and populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19383893      PMCID: PMC2763278          DOI: 10.1158/1055-9965.EPI-08-0936

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  32 in total

1.  Reduced fracture risk in users of thiazide diuretics.

Authors:  L Rejnmark; P Vestergaard; L Mosekilde
Journal:  Calcif Tissue Int       Date:  2005-02-23       Impact factor: 4.333

2.  Regular analgesic use and risk of endometrial cancer.

Authors:  Kirsten B Moysich; Julie A Baker; Kerry J Rodabaugh; Jeannine A Villella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-12       Impact factor: 4.254

Review 3.  Inflammation and endometrial cancer: a hypothesis.

Authors:  Francesmary Modugno; Roberta B Ness; Chu Chen; Noel S Weiss
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-12       Impact factor: 4.254

4.  Thiazide diuretics and the risk of gallbladder disease requiring surgery in women.

Authors:  Michael F Leitzmann; Chung-Jyi Tsai; Meir J Stampfer; Walter C Willett; Edward Giovannucci
Journal:  Arch Intern Med       Date:  2005-03-14

5.  Case-control study of endogenous steroid hormones and endometrial cancer.

Authors:  N Potischman; R N Hoover; L A Brinton; P Siiteri; J F Dorgan; C A Swanson; M L Berman; R Mortel; L B Twiggs; R J Barrett; G D Wilbanks; V Persky; J R Lurain
Journal:  J Natl Cancer Inst       Date:  1996-08-21       Impact factor: 13.506

Review 6.  Estrogen deficiency and bone loss: an inflammatory tale.

Authors:  M Neale Weitzmann; Roberto Pacifici
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

7.  Diabetes mellitus and risk of endometrial cancer: a meta-analysis.

Authors:  E Friberg; N Orsini; C S Mantzoros; A Wolk
Journal:  Diabetologia       Date:  2007-05-03       Impact factor: 10.122

8.  Relationships of uterine and ovarian tumors to pre-existing chronic conditions.

Authors:  Louise A Brinton; Lori C Sakoda; Kirsten Frederiksen; Mark E Sherman; Susanne K Kjaer; Barry I Graubard; Jorgen H Olsen; Lene Mellemkjaer
Journal:  Gynecol Oncol       Date:  2007-09-07       Impact factor: 5.482

9.  Diabetes, body size, and risk of endometrial cancer.

Authors:  S M Shoff; P A Newcomb
Journal:  Am J Epidemiol       Date:  1998-08-01       Impact factor: 4.897

10.  Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings.

Authors:  Victoria A Kirsh; Nancy Kreiger; Michelle Cotterchio; Margaret Sloan; Beth Theis
Journal:  Am J Epidemiol       Date:  2007-07-27       Impact factor: 4.897

View more
  30 in total

1.  Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort.

Authors:  Veronica Wendy Setiawan; Rayna K Matsuno; Galina Lurie; Lynne R Wilkens; Michael E Carney; Brian E Henderson; Laurence N Kolonel; Marc T Goodman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-04       Impact factor: 4.254

2.  Healthy eating index and ovarian cancer risk.

Authors:  Urmila Chandran; Elisa V Bandera; Melony G Williams-King; Lisa E Paddock; Lorna Rodriguez-Rodriguez; Shou-En Lu; Shameka Faulkner; Katherine Pulick; Sara H Olson
Journal:  Cancer Causes Control       Date:  2011-02-01       Impact factor: 2.506

3.  Consumption of sugary foods and drinks and risk of endometrial cancer.

Authors:  Melony G King; Urmila Chandran; Sara H Olson; Kitaw Demissie; Shou-En Lu; Niyati Parekh; Elisa V Bandera
Journal:  Cancer Causes Control       Date:  2013-05-09       Impact factor: 2.506

4.  History of uterine leiomyoma and risk of endometrial cancer in black women.

Authors:  Lauren A Wise; Todd R Sponholtz; Lynn Rosenberg; Lucile L Adams-Campbell; Wendy Kuohung; Michael P LaValley; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2016-02-29       Impact factor: 2.506

5.  Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium.

Authors:  Susan J Jordan; Renhua Na; Sharon E Johnatty; Lauren A Wise; Hans Olov Adami; Louise A Brinton; Chu Chen; Linda S Cook; Luigino Dal Maso; Immaculata De Vivo; Jo L Freudenheim; Christine M Friedenreich; Carlo La Vecchia; Susan E McCann; Kirsten B Moysich; Lingeng Lu; Sara H Olson; Julie R Palmer; Stacey Petruzella; Malcolm C Pike; Timothy R Rebbeck; Fulvio Ricceri; Harvey A Risch; Carlotta Sacerdote; Veronica Wendy Setiawan; Todd R Sponholtz; Xiao Ou Shu; Amanda B Spurdle; Elisabete Weiderpass; Nicolas Wentzensen; Hannah P Yang; Herbert Yu; Penelope M Webb
Journal:  Obstet Gynecol       Date:  2017-06       Impact factor: 7.661

6.  Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer.

Authors:  Amanda I Phipps; Garnet L Anderson; Barbara B Cochrane; Christopher I Li; Jean Wactawski-Wende; Gloria Y F Ho; Mary Jo O'Sullivan; Polly A Newcomb
Journal:  Horm Cancer       Date:  2012-07-24       Impact factor: 3.869

Review 7.  Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.

Authors:  Megan A Murphy; Britton Trabert; Hannah P Yang; Yikyung Park; Louise A Brinton; Patricia Hartge; Mark E Sherman; Albert Hollenbeck; Nicolas Wentzensen
Journal:  Cancer Causes Control       Date:  2012-09-13       Impact factor: 2.506

8.  Adherence to the dietary guidelines for Americans and endometrial cancer risk.

Authors:  Urmila Chandran; Elisa V Bandera; Melony G Williams-King; Camelia Sima; Sharon Bayuga; Katherine Pulick; Homer Wilcox; Ann G Zauber; Sara H Olson
Journal:  Cancer Causes Control       Date:  2010-07-23       Impact factor: 2.506

9.  Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort.

Authors:  Theodore M Brasky; Kirsten B Moysich; David E Cohn; Emily White
Journal:  Gynecol Oncol       Date:  2012-10-09       Impact factor: 5.482

10.  Use of nonsteroidal antiinflammatory drugs and risk of endometrial cancer.

Authors:  Clara Bodelon; Jennifer A Doherty; Chu Chen; Mary Anne Rossing; Noel S Weiss
Journal:  Am J Epidemiol       Date:  2009-11-06       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.